## LULU: lululemon athletica inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 1.14 indicates fundamental undervaluation. Quality metrics strong (ROE 41%, ROA 20%). Consistent execution (4/4 quarters beat estimates). Caution: declining volume (43% of avg), momentum weakening (-2.7% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($199.42)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Lululemon charts global expansion amid CEO hunt, boardroom battle**
- Source: Business in Vancouver | 20260105T220303 | Somewhat-Bearish | Relevance: 100%
- Lululemon is embarking on significant global expansion by signing franchise partnerships and opening new stores in Europe and India. This expansion comes amidst leadership uncertainty as CEO Calvin McDonald is set to depart, and the company searches for a new CEO. Founder Chip Wilson is also actively challenging the current board and leadership, pushing for changes and nominating new directors.

**2. Lululemon founder Chip Wilson scuffles with board amid CEO search**
- Source: Retail Dive | 20260105T173623 | Somewhat-Bearish | Relevance: 100%
- Lululemon founder Chip Wilson has nominated three individuals to the company's board and advocated for annual board elections, but the brand claims he has since declined to engage further despite the board's efforts to avoid a "costly and distracting proxy fight." Wilson, a major shareholder, criticized the board's oversight and the outgoing CEO's departure, especially as the company faces declining sales in North America and a search for a new CEO. The board, however, defends its experience and track record of significant revenue growth.

**3. lululemon's Q2 Earnings Echo Tariff & Cost Headwinds: Buy Now or Sell?**
- Source: MSN | 20260104T080823 | Neutral | Relevance: 100%
- This article discusses the Q2 earnings of Lululemon, highlighting the impact of tariff and cost headwinds on the company's financial performance. It also poses the question of whether investors should buy or sell the stock now.

**4. Lululemon founder Chip Wilson launches proxy fight for board shakeup**
- Source: FashionNetwork USA | 20260104T060844 | Somewhat-Bearish | Relevance: 100%
- Lululemon founder Chip Wilson has initiated a proxy fight by nominating three independent directors to the company's board, citing the failure of oversight after the unexplained departure of CEO Calvin McDonald. Wilson believes shareholders lack faith in the current board's ability to select and support a new CEO without stronger product experience among its members. Lululemon's shares have significantly decreased this year amid stiff competition and challenges with engaging younger shoppers, making board changes critical for future direction.

**5. What Is Tapestry, Inc.'s (NYSE:TPR) Share Price Doing?**
- Source: Simply Wall Street | 20260104T150319 | Neutral | Relevance: 62%
- Tapestry, Inc.'s shares have risen significantly by 31% recently, reaching their annual high and appearing fairly valued according to Simply Wall St's model, trading about 6.9% below its intrinsic value. The company has an optimistic future outlook, with earnings expected to double in the coming years, which should contribute to stronger cash flows and higher share value. Despite its current fair valuation, Tapestry's share price volatility presents potential future buying opportunities for investors.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 13, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-30 | Stifel | $210 | $210 | 0% |
| 2025-12-18 | Jefferies | $200 | $170 | +18% |
| 2025-12-12 | Wells Fargo | $175 | $160 | +9% |
| 2025-12-12 | UBS | $206 | $183 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-30 | Stifel | reit | Hold |
| 2025-12-18 | Jefferies | main | Hold |
| 2025-12-12 | Wells Fargo | main | Equal-Weight |
| 2025-12-12 | UBS | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.00M) |
| Sells | 3 ($0.39M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+3.9%)
- Blackrock Inc.: 8.8% (-0.9%)
- State Street Corpora: 4.2% (-1.1%)
- FMR, LLC: 3.6% (-65.8%)
- Geode Capital Manage: 2.7% (+0.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.7% 5d) with bearish MACD, trend may be turning.
2. Elevated short interest (8.9%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 13 raises (avg +13%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.14 suggests fair value with growth premium. Quality metrics strong (ROE 41%, ROA 20%, margin 16%). Balance sheet: strong liquidity (2.1x). Analyst sentiment positive (13 raises, avg +13%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $25.2B |
| Beta | 1.02 |
| 52W Range | $159.25 - $423.32 |
| Short Interest | 8.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.14 |
| Forward P/E | 16.8 |
| Current P/E | 16.3 |
| YoY Growth | -3.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 6.7% to 4.0% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.0pp (needs >4.0% for momentum thesis). MRS_5 at 0.6% confirms short-term momentum alignment. AM_20 at 4.1% shows strong absolute momentum above own 20MA. Outperforming sector by 4.3pp, stock-specific strength. Below SMA200 (0.95x), long-term trend not supportive. MACD histogram bearish (-0.58), momentum weakening. Volume at 43% of 20MA suggests lack of conviction. OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.96% (CS: 80) | Neutral |
| RSI_14 | 66.0 | Neutral |
| MACD Histogram | -0.58 | Bearish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 1.148x | Above |
| vs SMA200 | 0.955x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $212.40
- **Stop Loss:** $199.42 (6.1% risk)
- **Target:** $238.36 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 88
- **Position Value:** $18,691.20
- **Portfolio %:** 18.69%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.21 | $2.59 | +17.1% |
| 2025Q3 | $2.85 | $3.10 | +8.7% |
| 2025Q2 | $2.59 | $2.60 | +0.4% |
| 2025Q1 | $5.87 | $6.14 | +4.6% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*